Program Description: 


ISTH Academy Webinar: Thrombosis in Unusual Sites

Walter Ageno – Splanchnic Veins
The management of patients with splanchnic vein thrombosis is challenging because of the potential severity of the clinical presentation and because of the substantial risk of short and long-term complications, including recurrences and bleeding.
Evidence to drive clinical decisions is limited because no randomized controlled trials have been carried out in this setting and because of the heterogeneity of the patient population.
Aim of this webinar is to review available evidence in this setting and to discuss possible strategies for the management of patients with splanchnic vein thrombosis and the use of anticoagulant drugs in this setting.  
Jonathan Coutinho – Cerbral Sinus
In this presentation Dr. Coutinho will cover the epidemiology, diagnosis and treatment of cerebral venous thrombosis.


Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
Designation of Credit Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
More information and online registration: 

This meeting is being supported by Instrumentation Laboratory

Target audience: 

Internists, haematologists, vascular phyisicians

Learning objectives: 

At the end of this Webinar, the participants will be able to:

  • To review main risk factors, acute phase and long-term management strategies of splanchnic vein thrombosis, with particular focus on the use of anticoagulant therapies.
  • Knowledge on the risk factors for CVT and how these differ from VTE
  • Be familiar with the range of clinical manifestations that can observed in patients with CVT
  • Recognize the different brain parenchymal lesions that can occur in patients with CVT
  • Have an understanding on the different treatment modalities for CVT and know which therapy should be reserved for which patient
Faculty & credentials: 
Planning Committee:
Geoffrey Barnes, MD
Chris Ward, PhD
Stephen Watson, PhD
Yukio Ozaki
Walter Ageno
Jonathan Coutinho


Francesco Dentali

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  





Geoffrey Barnes, MDPortolaConsulting
 Blue Cross Blue Shield of MichiganResearch
Chris Ward, PhDBayerSpeaker
 Boehringer-IngelheimSpeaker, Advisory Board
 BMS/PfizerSpeaker, Advisory Board
Yukio OzakiThe Sysmex CorporationAdvisory Board
Jonathan CoutinhoBoehringer IngelheimCommittee member
Walter AgenoBayer, Boehringer IngelheimPrincipal Investigator, Advisory Board

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved






Lacey Schmeidler, MA
Phone number: 
+1 (919) 929-3807
Session date: 
09/21/2016 - 9:00am to 10:00am CDT
ISTH Webinar Library Once a Month
Carrboro, NC 27510
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.